Volume 15, Issue 6 (Special issue (Nov-Dec) 2021)                   mljgoums 2021, 15(6): 58-62 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ebrahimi M, Esmaeili H. Infective Endocarditis Caused by Staphylococcus aureus in a 6-Year-Old Girl with No History of Heart and Dental Problems: A Case Report. mljgoums. 2021; 15 (6) :58-62
URL: http://mlj.goums.ac.ir/article-1-1380-en.html
1- Children's Research Center, Golestan University of Medical Sciences, Gorgan, Iran
2- Children's Research Center, Golestan University of Medical Sciences, Gorgan, Iran , he_md1972@yahoo.com
Abstract:   (102 Views)
Infective endocarditis is rare in children but can cause significant morbidity and mortality. Streptococcus and Staphylococcus species are the leading causes of this disease. Staphylococcus is more common in people with underlying heart disease, and Streptococcus viridans is more common in people who have had a dental procedure. In general, any fever of unknown origin in children with an underlying heart problem should be carefully evaluated for endocarditis, and empiric therapy should be performed. The main symptoms of the disease include fever, new murmur, deterioration of the previous murmur, hematuria, embolic events, splenomegaly, bleeding splinter, Osler's nodes, Janeway lesion, and Roth spots. One of the important complications of infective endocarditis is cerebrovascular event and stroke. Herein, we describe a 6-year-old girl presented with fever and skin lesions and no history of underlying heart problem or dental procedure. The patient expired after three days of mitral valve infection with S. aureus.
Full-Text [PDF 605 kb]   (55 Downloads) |   |   Full-Text (HTML)  (24 Views)  
Research Article: Case Report | Subject: Microbiology
Received: 2021/04/12 | Accepted: 2021/11/4 | Published: 2021/10/18 | ePublished: 2021/10/18

References
1. Morris NA, Matiello M, Lyons JL, Samuels MA. Neurologic complications in infective endocarditis: identification, management, and impact on cardiac surgery. Neurohospitalist. 2014; 4(4): 213-22. [View at Publisher] [DOI:10.1177/1941874414537077] [PubMed] [Google Scholar]
2. Dhotre S, Jahagirdar V, Suryawanshi N, Davane M, Patil R, Nagoba B. Assessment of periodontitis and its role in viridans streptococcal bacteremia and infective endocarditis. Indian Heart J. 2018; 70(2): 225-32. [View at Publisher] [DOI:10.1016/j.ihj.2017.06.019] [PubMed] [Google Scholar]
3. Lin YT, Hsieh KS, Chen YS, Huang IF, Cheng MF. Infective endocarditis in children without underlying heart disease. J Microbiol Immunol Infect. 2013 Apr 1;46(2):121-8. [View at Publisher] [DOI:10.1016/j.jmii.2012.05.001] [PubMed] [Google Scholar]
4. Terpening MS, Buggy BP, Kauffman CA. Infective endocarditis: Clinical features in young and elderly patients. Am J Med. 1987 Oct 1;83(4):626-34. [View at Publisher] [DOI:10.1016/0002-9343(87)90890-4] [PubMed] [Google Scholar]
5. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association. Circulation. 2015; 132(15): 1435-86. [View at Publisher] [DOI] [PubMed] [Google Scholar]
6. Grüneberg RN, Antunes F, Chambers HF, Garau J, Graninger W, Menichetti F, et al. The role of glycopeptide antibiotics in the treatment of infective endocarditis. Int J Antimicrob Agents. 1999; 12(3): 191-8. [View at Publisher] [DOI:10.1016/S0924-8579(99)00006-0] [PubMed] [Google Scholar]
7. Cabell C, Abrutyn E, Karchmer A. Bacterial Endocarditis: The Disease, Treatment, and Prevention. Circulation. 2003; 129(20): e185-7. [View at Publisher] [DOI:10.1161/01.CIR.0000071082.36561.F1] [Google Scholar]
8. Gudiol F, Aguado JM, Almirante B, Bouza E, Cercenado E, Domínguez MÁ, et al. Diagnosis and treatment of bacteremia and endocarditis due to Staphylococcus aureus. A clinical guideline from the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC). Enferm Infecc Microbiol Clin. 2015 Nov 1;33(9):625.e1-625.e23. [View at Publisher] [DOI:10.1016/j.eimc.2015.03.015] [PubMed] [Google Scholar]
9. Johnson MD, Johnson CD. Neurologic presentations of infective endocarditis. Neurol Clin. 2010; 28(1): 311-21. [DOI:10.1016/j.ncl.2009.09.001] [PubMed] [Google Scholar]
10. Rubinos C, Ruland S. Neurologic Complications in the Intensive Care Unit. Curr Neurol Neurosci Rep. 2016; 16(6). [DOI] [PubMed] [Google Scholar]
11. Deprèle C, Berthelot P, Lemetayer F, Comtet C, Fresard A, Cazorla C, et al. Risk factors for systemic emboli in infective endocarditis. Clin Microbiol Infect. 2004; 10(1): 46-53. [View at Publisher] [DOI:10.1111/j.1469-0691.2004.00735.x] [PubMed] [Google Scholar]
12. Rizzi M, Ravasio V, Carobbio A, Mattucci I, Crapis M, Stellini R, et al. Predicting the occurrence of embolic events: an analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI). BMC Infect Dis. 2014; 14: 230. [View at Publisher] [DOI:10.1186/1471-2334-14-230] [PubMed] [Google Scholar]
13. Smith EE, Saposnik G, Biessels GJ, Doubal FN, Fornage M, Gorelick PB, et al. Prevention of Stroke in Patients With Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2017; 48(2): e44-e71 [View at Publisher] [DOI:10.1161/STR.0000000000000116] [PubMed] [Google Scholar]
14. Roach ES, Golomb MR, Adams R, Biller J, Daniels S, Deveber G, et al. Management of stroke in infants and children: a scientific statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke. 2008; 39(9): 2644-91. [View at Publisher] [DOI:10.1161/STROKEAHA.108.189696] [PubMed] [Google Scholar]
15. Demaerschalk BM, Kleindorfer DO, Adeoye OM, Demchuk AM, Fugate JE, Grotta JC, et al. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2016; 47(2): 581-641. [View at Publisher] [DOI:10.1161/STR.0000000000000086] [PubMed] [Google Scholar]
16. van der Zijden T, Mondelaers A, Yperzeele L, Voormolen M, Parizel PM. Current concepts in imaging and endovascular treatment of acute ischemic stroke: implications for the clinician [Internet]. Vol. 10, Insights into Imaging. Springer Verlag; 2019 [cited 2021 Apr 12]. p. 64. Available from: https://insightsimaging.springeropen.com/articles/10.1186/s13244-019-0744-4 [View at Publisher] [DOI:10.1186/s13244-019-0744-4] [PubMed] [Google Scholar]
17. Winder AJ, Siemonsen S, Flottmann F, Thomalla G, Fiehler J, Forkert ND. Technical considerations of multi-parametric tissue outcome prediction methods in acute ischemic stroke patients. Sci Rep [Internet]. 2019 Dec 1 [cited 2021 Apr 12];9(1):1-12. Available from: www.nature.com/scientificreports [View at Publisher] [DOI:10.1038/s41598-019-49460-y] [PubMed] [Google Scholar]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2007 All Rights Reserved | Medical Laboratory Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.